Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 160

1.

Cost-effectiveness of combination disease-modifying antirheumatics vs. tumour necrosis factor inhibitors in active rheumatoid arthritis: TACIT trial.

Patel A, Heslin M, Scott DL, Stringer D, Birrell F, Ibrahim F.

Arthritis Care Res (Hoboken). 2019 Jan 10. doi: 10.1002/acr.23830. [Epub ahead of print]

PMID:
30629813
2.

Healthcare disparities in outcomes of patients with resectable pancreatic cancer.

Moaven O, Richman JS, Reddy S, Wang T, Heslin MJ, Contreras CM.

Am J Surg. 2019 Apr;217(4):725-731. doi: 10.1016/j.amjsurg.2018.12.007. Epub 2018 Dec 10.

PMID:
30583797
3.

Timed Stair-Climbing as a Surrogate Marker for Sarcopenia Measurements in Predicting Surgical Outcomes.

Baker S, Waldrop MG, Swords J, Wang T, Heslin M, Contreras C, Reddy S.

J Gastrointest Surg. 2018 Dec 3. doi: 10.1007/s11605-018-4042-0. [Epub ahead of print]

PMID:
30511131
4.

Nurse-led psychological intervention for type 2 diabetes: a cluster randomised controlled trial (Diabetes-6 study) in primary care.

Ismail K, Winkley K, de Zoysa N, Patel A, Heslin M, Graves H, Thomas S, Stringer D, Stahl D, Amiel SA.

Br J Gen Pract. 2018 Aug;68(673):e531-e540. doi: 10.3399/bjgp18X696185. Epub 2018 Jul 16.

PMID:
30012812
5.

A Structured Compensation Plan Improves But Does Not Erase the Sex Pay Gap in Surgery.

Morris M, Chen H, Heslin MJ, Krontiras H.

Ann Surg. 2018 Sep;268(3):442-448. doi: 10.1097/SLA.0000000000002928.

PMID:
29979249
6.

NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018.

Shah MH, Goldner WS, Halfdanarson TR, Bergsland E, Berlin JD, Halperin D, Chan J, Kulke MH, Benson AB, Blaszkowsky LS, Eads J, Engstrom PF, Fanta P, Giordano T, He J, Heslin MJ, Kalemkerian GP, Kandeel F, Khan SA, Kidwai WZ, Kunz PL, Kuvshinoff BW, Lieu C, Pillarisetty VG, Saltz L, Sosa JA, Strosberg JR, Sussman CA, Trikalinos NA, Uboha NA, Whisenant J, Wong T, Yao JC, Burns JL, Ogba N, Zuccarino-Catania G.

J Natl Compr Canc Netw. 2018 Jun;16(6):693-702. doi: 10.6004/jnccn.2018.0056.

PMID:
29891520
7.

The effects of tenure and promotion on surgeon productivity.

Lam A, Heslin MJ, Tzeng CD, Chen H.

J Surg Res. 2018 Jul;227:67-71. doi: 10.1016/j.jss.2018.02.020. Epub 2018 Mar 12.

PMID:
29804864
8.

Inpatient use and area-level socio-environmental factors in people with psychosis.

Heslin M, Khondoker M, Shetty H, Pritchard M, Jones PB, Osborn D, Kirkbride JB, Roberts A, Stewart R.

Soc Psychiatry Psychiatr Epidemiol. 2018 Oct;53(10):1133-1140. doi: 10.1007/s00127-018-1534-x. Epub 2018 May 23.

9.

Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.

von Mehren M, Randall RL, Benjamin RS, Boles S, Bui MM, Ganjoo KN, George S, Gonzalez RJ, Heslin MJ, Kane JM 3rd, Keedy V, Kim E, Koon H, Mayerson J, McCarter M, McGarry SV, Meyer C, Morris ZS, O'Donnell RJ, Pappo AS, Paz IB, Petersen IA, Pfeifer JD, Riedel RF, Ruo B, Schuetze S, Tap WD, Wayne JD, Bergman MA, Scavone JL.

J Natl Compr Canc Netw. 2018 May;16(5):536-563. doi: 10.6004/jnccn.2018.0025.

PMID:
29752328
10.

Comparison of effectiveness and cost-effectiveness of an intensive community supported discharge service versus treatment as usual for adolescents with psychiatric emergencies: a randomised controlled trial.

Ougrin D, Corrigall R, Poole J, Zundel T, Sarhane M, Slater V, Stahl D, Reavey P, Byford S, Heslin M, Ivens J, Crommelin M, Abdulla Z, Hayes D, Middleton K, Nnadi B, Taylor E.

Lancet Psychiatry. 2018 Jun;5(6):477-485. doi: 10.1016/S2215-0366(18)30129-9. Epub 2018 May 3.

11.

Early sustained recovery following first episode psychosis: Evidence from the AESOP10 follow-up study.

Lappin JM, Heslin M, Lomas B, Jones PB, Doody GA, Reininghaus UA, Croudace T, Craig T, Fearon P, Murray RM, Dazzan P, Morgan C.

Schizophr Res. 2018 Sep;199:341-345. doi: 10.1016/j.schres.2018.03.014. Epub 2018 Mar 20.

PMID:
29571751
12.

Psychotic major depression: challenges in clinical practice and research.

Heslin M, Young AH.

Br J Psychiatry. 2018 Mar;212(3):131-133. doi: 10.1192/bjp.2017.43.

PMID:
29486823
13.

A Comparison of Different Approaches for Costing Medication Use in an Economic Evaluation.

Heslin M, Babalola O, Ibrahim F, Stringer D, Scott D, Patel A.

Value Health. 2018 Feb;21(2):185-192. doi: 10.1016/j.jval.2017.02.001. Erratum in: Value Health. 2018 Jul;21(7):895.

14.

Randomised controlled trial to improve health and reduce substance use in established psychosis (IMPaCT): cost-effectiveness of integrated psychosocial health promotion.

Heslin M, Patel A, Stahl D, Gardner-Sood P, Mushore M, Smith S, Greenwood K, Onagbesan O, O'Brien C, Fung C, Ohlsen R, Hopkins D, Lowe P, Arbuthnot M, Mutatsa S, Todd G, Kolliakou A, Lally J, Stubbs B, Ismail K, David A, Murray R, Atakan Z, Gaughran F.

BMC Psychiatry. 2017 Dec 22;17(1):407. doi: 10.1186/s12888-017-1570-1.

15.

JQ1 Induces DNA Damage and Apoptosis, and Inhibits Tumor Growth in a Patient-Derived Xenograft Model of Cholangiocarcinoma.

Garcia PL, Miller AL, Gamblin TL, Council LN, Christein JD, Arnoletti JP, Heslin MJ, Reddy S, Richardson JH, Cui X, van Waardenburg RCAM, Bradner JE, Yang ES, Yoon KJ.

Mol Cancer Ther. 2018 Jan;17(1):107-118. doi: 10.1158/1535-7163.MCT-16-0922. Epub 2017 Nov 15.

16.

Patient Perceptions About Their Physician in 2 Words: The Good, the Bad, and the Ugly.

Singletary B, Patel N, Heslin M.

JAMA Surg. 2017 Dec 1;152(12):1169-1170. doi: 10.1001/jamasurg.2017.3851. No abstract available.

PMID:
29049444
17.

Implementation and utilization of the molecular tumor board to guide precision medicine.

Harada S, Arend R, Dai Q, Levesque JA, Winokur TS, Guo R, Heslin MJ, Nabell L, Nabors LB, Limdi NA, Roth KA, Partridge EE, Siegal GP, Yang ES.

Oncotarget. 2017 Jun 14;8(34):57845-57854. doi: 10.18632/oncotarget.18471. eCollection 2017 Aug 22. Review.

18.

Gaps in the Postoperative Conversation: A Comprehensive Review of Current Practices and the Unmet Needs of Surgeons, Families, and Waiting Room Personnel.

Singletary B, Patel N, Mims A, Smedley A, Swords J, O'Bierne R, Morris MS, Safford M, Heslin M.

Am Surg. 2017 Jul 1;83(7):812-820.

PMID:
28738957
19.

Increased pancreatic cancer survival with greater lymph node retrieval in the National Cancer Data Base.

Contreras CM, Lin CP, Oster RA, Reddy S, Wang T, Vickers S, Heslin M.

Am J Surg. 2017 Sep;214(3):442-449. doi: 10.1016/j.amjsurg.2017.06.036. Epub 2017 Jul 1.

20.

Clinical effectiveness, cost-effectiveness and acceptability of low-intensity interventions in the management of obsessive-compulsive disorder: the Obsessive-Compulsive Treatment Efficacy randomised controlled Trial (OCTET).

Lovell K, Bower P, Gellatly J, Byford S, Bee P, McMillan D, Arundel C, Gilbody S, Gega L, Hardy G, Reynolds S, Barkham M, Mottram P, Lidbetter N, Pedley R, Molle J, Peckham E, Knopp-Hoffer J, Price O, Connell J, Heslin M, Foley C, Plummer F, Roberts C.

Health Technol Assess. 2017 Jun;21(37):1-132. doi: 10.3310/hta21370.

21.

Cognitive Bias Modification for paranoia (CBM-pa): study protocol for a randomised controlled trial.

Yiend J, Trotta A, Meek C, Dzafic I, Baldus N, Crane B, Kabir T, Stahl D, Heslin M, Shergill S, McGuire P, Peters E.

Trials. 2017 Jun 29;18(1):298. doi: 10.1186/s13063-017-2037-x.

22.

Low-intensity cognitive-behaviour therapy interventions for obsessive-compulsive disorder compared to waiting list for therapist-led cognitive-behaviour therapy: 3-arm randomised controlled trial of clinical effectiveness.

Lovell K, Bower P, Gellatly J, Byford S, Bee P, McMillan D, Arundel C, Gilbody S, Gega L, Hardy G, Reynolds S, Barkham M, Mottram P, Lidbetter N, Pedley R, Molle J, Peckham E, Knopp-Hoffer J, Price O, Connell J, Heslin M, Foley C, Plummer F, Roberts C.

PLoS Med. 2017 Jun 27;14(6):e1002337. doi: 10.1371/journal.pmed.1002337. eCollection 2017 Jun.

23.

Ethnicity and long-term course and outcome of psychotic disorders in a UK sample: the ÆSOP-10 study.

Morgan C, Fearon P, Lappin J, Heslin M, Donoghue K, Lomas B, Reininghaus U, Onyejiaka A, Croudace T, Jones PB, Murray RM, Doody GA, Dazzan P.

Br J Psychiatry. 2017 Aug;211(2):88-94. doi: 10.1192/bjp.bp.116.193342. Epub 2017 Jun 22.

24.

Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors.

Demjaha A, Lappin JM, Stahl D, Patel MX, MacCabe JH, Howes OD, Heslin M, Reininghaus UA, Donoghue K, Lomas B, Charalambides M, Onyejiaka A, Fearon P, Jones P, Doody G, Morgan C, Dazzan P, Murray RM.

Psychol Med. 2017 Aug;47(11):1981-1989. doi: 10.1017/S0033291717000435. Epub 2017 Apr 11.

PMID:
28395674
25.

Chemoproteomics-enabled covalent ligand screen reveals a cysteine hotspot in reticulon 4 that impairs ER morphology and cancer pathogenicity.

Bateman LA, Nguyen TB, Roberts AM, Miyamoto DK, Ku WM, Huffman TR, Petri Y, Heslin MJ, Contreras CM, Skibola CF, Olzmann JA, Nomura DK.

Chem Commun (Camb). 2017 Jun 29;53(53):7234-7237. doi: 10.1039/c7cc01480e.

26.

Argininosuccinate Synthase 1 is a Metabolic Regulator of Colorectal Cancer Pathogenicity.

Bateman LA, Ku WM, Heslin MJ, Contreras CM, Skibola CF, Nomura DK.

ACS Chem Biol. 2017 Apr 21;12(4):905-911. doi: 10.1021/acschembio.6b01158. Epub 2017 Mar 1.

PMID:
28229591
27.

Association between Hepatitis C Virus Infection, p53 Phenotypes, and Gene Variants of Adenomatous Polyposis Coli in Hepatocellular Carcinomas.

Council LN, Shanmugam C, Suswam EA, Katkoori VR, Heslin MJ, Hanna A, Jhala NC, Varambally S, Manne U.

J Dig Dis Hepatol. 2016;2016(5). pii: JDDH-121. Epub 2016 Dec 23.

28.

Chemoproteomic Screening of Covalent Ligands Reveals UBA5 As a Novel Pancreatic Cancer Target.

Roberts AM, Miyamoto DK, Huffman TR, Bateman LA, Ives AN, Akopian D, Heslin MJ, Contreras CM, Rape M, Skibola CF, Nomura DK.

ACS Chem Biol. 2017 Apr 21;12(4):899-904. doi: 10.1021/acschembio.7b00020. Epub 2017 Feb 15.

PMID:
28186401
29.

Outcomes following first-episode psychosis - Why we should intervene early in all ages, not only in youth.

Lappin JM, Heslin M, Jones PB, Doody GA, Reininghaus UA, Demjaha A, Croudace T, Jamieson-Craig T, Donoghue K, Lomas B, Fearon P, Murray RM, Dazzan P, Morgan C.

Aust N Z J Psychiatry. 2016 Nov;50(11):1055-1063. Epub 2016 Oct 18.

30.

Depression: an exploratory parallel-group randomised controlled trial of Antenatal guided self help for WomeN (DAWN): study protocol for a randomised controlled trial.

Trevillion K, Domoney J, Pickles A, Bick D, Byford S, Heslin M, Milgrom J, Mycroft R, Pariante C, Ryan E, Hunter M, Howard LM.

Trials. 2016 Oct 18;17(1):503.

31.

Scaling-up services for psychosis, depression and epilepsy in sub-Saharan Africa and South Asia: development and application of a mental health systems planning tool (OneHealth).

Chisholm D, Heslin M, Docrat S, Nanda S, Shidhaye R, Upadhaya N, Jordans M, Abdulmalik J, Olayiwola S, Gureje O, Kizza D, Mugisha J, Kigozi F, Hanlon C, Adugna M, Sanders R, Pretorius C, Thornicroft G, Lund C.

Epidemiol Psychiatr Sci. 2017 Jun;26(3):234-244. doi: 10.1017/S2045796016000408. Epub 2016 Sep 19.

PMID:
27641074
32.

Understanding the Value of Both Laparoscopic and Robotic Approaches Compared to the Open Approach in Colorectal Surgery.

Hollis RH, Cannon JA, Singletary BA, Korb ML, Hawn MT, Heslin MJ.

J Laparoendosc Adv Surg Tech A. 2016 Nov;26(11):850-856. Epub 2016 Jul 11.

PMID:
27398733
33.

Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.

von Mehren M, Randall RL, Benjamin RS, Boles S, Bui MM, Conrad EU 3rd, Ganjoo KN, George S, Gonzalez RJ, Heslin MJ, Kane JM 3rd, Koon H, Mayerson J, McCarter M, McGarry SV, Meyer C, O'Donnell RJ, Pappo AS, Paz IB, Petersen IA, Pfeifer JD, Riedel RF, Schuetze S, Schupak KD, Schwartz HS, Tap WD, Wayne JD, Bergman MA, Scavone J.

J Natl Compr Canc Netw. 2016 Jun;14(6):758-86.

PMID:
27283169
34.

RNA sequencing of pancreatic adenocarcinoma tumors yields novel expression patterns associated with long-term survival and reveals a role for ANGPTL4.

Kirby MK, Ramaker RC, Gertz J, Davis NS, Johnston BE, Oliver PG, Sexton KC, Greeno EW, Christein JD, Heslin MJ, Posey JA, Grizzle WE, Vickers SM, Buchsbaum DJ, Cooper SJ, Myers RM.

Mol Oncol. 2016 Oct;10(8):1169-82. doi: 10.1016/j.molonc.2016.05.004. Epub 2016 May 26.

35.

Ten-year outcomes in first episode psychotic major depression patients compared with schizophrenia and bipolar patients.

Heslin M, Lappin JM, Donoghue K, Lomas B, Reininghaus U, Onyejiaka A, Croudace T, Jones PB, Murray RM, Fearon P, Doody GA, Dazzan P, Craig TJ, Morgan C.

Schizophr Res. 2016 Oct;176(2-3):417-422. doi: 10.1016/j.schres.2016.04.049. Epub 2016 May 26.

36.

Costs of the police service and mental healthcare pathways experienced by individuals with enduring mental health needs.

Heslin M, Callaghan L, Barrett B, Lea S, Eick S, Morgan J, Bolt M, Thornicroft G, Rose D, Healey A, Patel A.

Br J Psychiatry. 2017 Feb;210(2):157-164. doi: 10.1192/bjp.bp.114.159129. Epub 2016 Mar 17.

37.

Diagnostic Stability of ICD/DSM First Episode Psychosis Diagnoses: Meta-analysis.

Fusar-Poli P, Cappucciati M, Rutigliano G, Heslin M, Stahl D, Brittenden Z, Caverzasi E, McGuire P, Carpenter WT.

Schizophr Bull. 2016 Nov;42(6):1395-1406. doi: 10.1093/schbul/sbw020. Epub 2016 Mar 15.

38.

Timed Stair Climbing Is the Single Strongest Predictor of Perioperative Complications in Patients Undergoing Abdominal Surgery.

Reddy S, Contreras CM, Singletary B, Bradford TM, Waldrop MG, Mims AH, Smedley WA, Swords JA, Wang TN, Heslin MJ.

J Am Coll Surg. 2016 Apr;222(4):559-66. doi: 10.1016/j.jamcollsurg.2016.01.010. Epub 2016 Jan 28.

39.

Decision analytic model exploring the cost and cost-offset implications of street triage.

Heslin M, Callaghan L, Packwood M, Badu V, Byford S.

BMJ Open. 2016 Feb 11;6(2):e009670. doi: 10.1136/bmjopen-2015-009670.

40.

A Role for the Early Warning Score in Early Identification of Critical Postoperative Complications.

Hollis RH, Graham LA, Lazenby JP, Brown DM, Taylor BB, Heslin MJ, Rue LW, Hawn MT.

Ann Surg. 2016 May;263(5):918-23. doi: 10.1097/SLA.0000000000001514.

PMID:
26692076
41.

Biological and psychosocial risk factors for psychotic major depression.

Heslin M, Desai R, Lappin JM, Donoghue K, Lomas B, Reininghaus U, Onyejiaka A, Croudace T, Jones PB, Murray RM, Fearon P, Doody GA, Dazzan P, Fisher HL, Demjaha A, Craig T, Morgan C.

Soc Psychiatry Psychiatr Epidemiol. 2016 Feb;51(2):233-45. doi: 10.1007/s00127-015-1131-1. Epub 2015 Oct 31.

42.

The BET bromodomain inhibitor JQ1 suppresses growth of pancreatic ductal adenocarcinoma in patient-derived xenograft models.

Garcia PL, Miller AL, Kreitzburg KM, Council LN, Gamblin TL, Christein JD, Heslin MJ, Arnoletti JP, Richardson JH, Chen D, Hanna CA, Cramer SL, Yang ES, Qi J, Bradner JE, Yoon KJ.

Oncogene. 2016 Feb 18;35(7):833-45. doi: 10.1038/onc.2015.126. Epub 2015 May 11.

PMID:
25961927
43.

Diagnostic change 10 years after a first episode of psychosis.

Heslin M, Lomas B, Lappin JM, Donoghue K, Reininghaus U, Onyejiaka A, Croudace T, Jones PB, Murray RM, Fearon P, Dazzan P, Morgan C, Doody GA.

Psychol Med. 2015 Oct;45(13):2757-69. doi: 10.1017/S0033291715000720. Epub 2015 May 4.

44.

The management of individuals with enduring moderate to severe mental health needs: a participatory evaluation of client journeys and the interface of mental health services with the criminal justice system in Cornwall.

Lea S, Callaghan L, Eick S, Heslin M, Morgan J, Bolt M, Healey A, Barrett B, Rose D, Patel A, Thornicroft G.

Southampton (UK): NIHR Journals Library; 2015 Apr.

45.

Ten-Year Outcomes of First-Episode Psychoses in the MRC ÆSOP-10 Study.

Revier CJ, Reininghaus U, Dutta R, Fearon P, Murray RM, Doody GA, Croudace T, Dazzan P, Heslin M, Onyejiaka A, Kravariti E, Lappin J, Lomas B, Kirkbride JB, Donoghue K, Morgan C, Jones PB.

J Nerv Ment Dis. 2015 May;203(5):379-86. doi: 10.1097/NMD.0000000000000295.

46.

Patterns of Failure for Lymph Node-Positive Resected Pancreatic Adenocarcinoma After Adjuvant Radiotherapy or Gemcitabine-based Chemotherapy Alone.

McDonald AM, Dulaney CR, López-Araujo J, Posey JA, Keene KS, Christein JD, Heslin MJ, Wood TE, Jacob R.

J Gastrointest Cancer. 2015 Jun;46(2):149-55. doi: 10.1007/s12029-015-9702-7.

PMID:
25782589
47.

Tumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trial.

Scott DL, Ibrahim F, Farewell V, O'Keeffe AG, Walker D, Kelly C, Birrell F, Chakravarty K, Maddison P, Heslin M, Patel A, Kingsley GH.

BMJ. 2015 Mar 13;350:h1046. doi: 10.1136/bmj.h1046.

48.

A systematic review of the economic evidence for interventions for family carers of stroke patients.

Heslin M, Forster A, Healey A, Patel A.

Clin Rehabil. 2016 Feb;30(2):119-33. doi: 10.1177/0269215515575334. Epub 2015 Mar 10. Review.

49.

Neuroendocrine tumors, version 1.2015.

Kulke MH, Shah MH, Benson AB 3rd, Bergsland E, Berlin JD, Blaszkowsky LS, Emerson L, Engstrom PF, Fanta P, Giordano T, Goldner WS, Halfdanarson TR, Heslin MJ, Kandeel F, Kunz PL, Kuvshinoff BW 2nd, Lieu C, Moley JF, Munene G, Pillarisetty VG, Saltz L, Sosa JA, Strosberg JR, Vauthey JN, Wolfgang C, Yao JC, Burns J, Freedman-Cass D; National comprehensive cancer network.

J Natl Compr Canc Netw. 2015 Jan;13(1):78-108.

PMID:
25583772
50.

Randomised controlled trial of tumour necrosis factor inhibitors against combination intensive therapy with conventional disease-modifying antirheumatic drugs in established rheumatoid arthritis: the TACIT trial and associated systematic reviews.

Scott DL, Ibrahim F, Farewell V, O'Keeffe AG, Ma M, Walker D, Heslin M, Patel A, Kingsley G.

Health Technol Assess. 2014 Oct;18(66):i-xxiv, 1-164. doi: 10.3310/hta18660.

Supplemental Content

Loading ...
Support Center